Pfizer to split into three units
In this article:
Pfizer said it'll reorganize into three units, separating its consumer healthcare business that the U.S. drugmaker has been trying to sell since last year. Fred Katayama reports.
Advertisement
Recommended Stories
Are Stocks Going to Crash? This Forecasting Tool Hasn't Been Wrong in 65 Years, and It Has a Sobering Message for Wall Street
This historically flawless predictive tool has accurately foreshadowed what's to come for the U.S. economy since 1959.
Motley FoolA Once-in-a-Decade Opportunity: 3 Magnificent Dividend Stocks Down Between 19% and 28% to Buy Now and Hold Forever
These three low-volatility, dividend-growth stocks offer the potential to rebound while trading near decade-low valuations.
Motley FoolQuantumScape Making Big Moves: Time to Buy Before It Skyrockets?
The battery start-up might reach its ambitions sooner than expected.
Motley FoolForget Energy Transfer; Buy This Magnificent High-Yield Stock Instead
Energy Transfer has a huge 8% yield, but you'd be better off with this still massive, 7.3%-yielding alternative.
Motley FoolFact or Fiction: Congress Stole From Social Security and Should Return the Money It's Taken, With Interest
Did lawmakers really pilfer Social Security's piggy bank? Here's the truth.
Motley Fool2 Artificial Intelligence (AI) Stocks to Buy Now, and 1 to Avoid Like the Plague
It's clear that the shine is coming off of some AI stocks, while others remain solid long-term investments.
Motley Fool1 Stock I Wouldn't Touch With a 10-Foot Pole
There is no shortage of reasons to be bearish about this business.
Motley FoolShould You Buy the Best-Performing Vanguard Dividend ETF of the Decade?
It is beating its dividend peers by a wide margin.
Motley FoolMeet the Supercharged Growth Stock That's a Shoo-in to Join Microsoft in the $3 Trillion Club
Multiple growth drivers and strong secular tailwinds should combine to drive this artificial intelligence (AI) pioneer higher.
Motley FoolMassive News for Intel Stock Investors
Intel was hit with more bad news that has enormous implications for investors.
Motley Fool